Dr. (Prof.) Jyoti Bajpai, MD, DM
A medical oncologist, passionate to learn new things. Extremely open to connect to various stakeholders across geographic boundaries. Exceptionally good in building and maintaining teams.
- Lead-Medical and Precision Oncology, Mumbai and Maharashtra Region, Apollo Hospitals, Navi Mumbai.
- Visiting Consultant, Sir H.N. Reliance Foundation Hospital.
- Former Professor and Convener Breast DMG, Tata Memorial Centre, Mumbai.
- Founder General Secretary Immuno-Oncology Society of India.
- Core Interests: Precision Therapy, Immunooncology, Targeted Therapy, Enhanced Supportive Care of Breast, Sarcomas, Gynec, Lung, GU, GI, Rare and Challenging Cancers like AYA, Geriatric, Pregnancy Related
Specializations
GENERAL
Precision Oncology
5-7 words to describe this specialization
Immunotherapy/Targeted Therapy
5-7 words to describe this specialization
Women Cancers
5-7 words to describe this specialization
Rare Cancer Treatment
5-7 words to describe this specialization
CHALLENGING SITUATIONS IN ONCOLOGY
Adolescent and Young Adult Cancers
5-7 words to describe this specialization
Geriatric/Elderly Cancers
5-7 words to describe this specialization
Immunocompromised Patient Cancers
5-7 words to describe this specialization
Comorbidities Patient Cancers
5-7 words to describe this specialization
Dr. Jyoti Bajpai’s oncology training involves leading institutes in India and abroad including All India Institute of Medical sciences, Memorial Sloan catering, John Hopkins and she is an ESMO leader’s generation programme graduate.
She is an avid multitasker and was pivotal in several initiatives in the Country and SAARC region inclusive of, pioneering the Indian Immuno-oncology society of India (founder general secretary) and Women in oncology (W4O) –India and SAARC nations (founder chair). Additionally, she is representing country in reputed international societies as a core member in society of immunotherapy of cancer (SITC) global access and impact committee member, as well as ESMO-W4O and ESMO-Immunotherapy track faculty. With these global and national organizations she is trying hard to work towards workforce equity especially to establish a gender neutral environment in oncology.
She is an important contributor towards development of prestigious international guidelines for ESMO, SITC, ABC, BCY-7 and ESMO-PAGA, guidelines for breast cancer, sarcoma and Immunotherapy. Her other research work includes international and national publications (~200) in the field of Rare cancers (sarcomas, pregnancy associated cancers), building low-cost efficacious protocols for low–middle income countries, breast and gynecological cancers, gender equality and Immuno-oncology.
Besides, She is having a rich experience to be in editorial and reviewers boards of international and national Journals, Primary investigator of a good number of randomized trials and mentoring students from institutional, national and international forums.